Korro Bio, Inc.
KRRO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001703647
In the last 90 days, Korro Bio, Inc. insiders filed 1 open-market purchase and 8 sales; 106 institutions reported holding it in 13F filings for Q2 2026, worth $190.1M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Korro Bio, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 83
- −8 vs. Q3 2025
- Shares held
- 7.56M
- −1.83M (−19.5%) vs. Q3 2025
- Total value
- $60.6M
- −$387.3M (−86.5%) vs. Q3 2025
- New holders
- 22
- 24 more added
- Sold out
- 30
- 22 more reduced
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KRRO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 106 | $190.1M |
| Q1 2026 | 99 | $144.8M |
| Q4 2025 | 83 | $60.6M |
| Q3 2025 | 92 | $465.5M |
| Q2 2025 | 71 | $114.8M |
| Q1 2025 | 75 | $169.0M |
| Q4 2024 | 84 | $359.6M |
| Q3 2024 | 71 | $285.3M |
| Q2 2024 | 64 | $285.7M |
| Q1 2024 | 49 | $618.6M |
| Q4 2023 | 40 | $301.5M |
| Q3 2023 | 42 | $2.58M |
| Q2 2023 | 41 | $1.67M |
| Q1 2023 | 43 | $2.52M |
| Q4 2022 | 50 | $28.3M |
| Q3 2022 | 55 | $14.1M |
| Q2 2022 | 58 | $13.0M |
| Q1 2022 | 86 | $33.1M |
| Q4 2021 | 84 | $90.2M |
| Q3 2021 | 88 | $130.4M |
| Q2 2021 | 91 | $193.9M |
| Q1 2021 | 115 | $186.6M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Korro Bio, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nuveen, LLC | 0 | $0 | 0.00% | −9,264−100.0% | Sold out |
| Alliancebernstein L.P. | 0 | $0 | 0.00% | −7,700−100.0% | Sold out |
| Wealth Forward, LLC | 0 | $0 | 0.00% | −5,009−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −4,375−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −3,945−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −3,610−100.0% | Sold out |
| Essential Partners LLC | 0 | $0 | 0.00% | −394−100.0% | Sold out |
| Versant Capital Management, Inc | 0 | $0 | 0.00% | −271−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −89−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −83−100.0% | Sold out |
| Wealthspire Advisors, LLC | 0 | $0 | 0.00% | −65−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −18−100.0% | Sold out |
| Qiming U.S. Ventures Management, LLC | – | – | – | – | Not filed |